• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Thrombosis (2100)
Event Date 02/08/2016
Event Type  Injury  
Manufacturer Narrative
As the device was not returned, no evaluation of the device could be performed.
 
Event Description
The following literature article was reviewed: "uncertain patency of covered stents placed for traumatic axillosubclavian artery injury" atish chopra, md, et al.(journal of the american college of surgeons 2016;223:174e183.Published by elsevier inc.On behalf of the american college of surgeons.) revised january 22, 2016; accepted february 8, 2016.Background: traumatic axillosubclavian artery injuries (asais) are uncommon but devastating.There is increasing acceptance of covered stent use for asais.However, epidemiologic and long-term outcomes data are limited.We investigated national trends in asai management and our institutional outcomes after emergent covered stent placement and open surgical repairs for asais.Study design: a review of the national trauma data bank from 2010 to 2012 was performed for epidemiologic data.A single-center, retrospective review of consecutive patients with asais between january 2010 and august 2014 was also performed.On page 179 there is a reference to thrombus development in 2 of 8 patients implanted with gore® viabahn® endoprostheses to treat concomitant subclavian and axillary artery injuries.This event will capture the patient implanted with one gore® viabahn® endoprosthesis with post-operative thrombus development.
 
Manufacturer Narrative
Added method code 2 - device disposition.The article references additional patient implanted with one gore® viabahn® endoprostheses with post operative thrombus development, reported under mfr report number - 2017233-2020-00328.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key10027225
MDR Text Key194324626
Report Number2017233-2020-00329
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 07/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received05/05/2020
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received07/08/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age35 YR
-
-